368 related articles for article (PubMed ID: 23230718)
1. The rate of adverse events following BCG vaccination in Poland.
Krysztopa-Grzybowska K; Paradowska-Stankiewicz I; Lutyńska A
Przegl Epidemiol; 2012; 66(3):465-9. PubMed ID: 23230718
[TBL] [Abstract][Full Text] [Related]
2. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
Szczuka I
Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
[TBL] [Abstract][Full Text] [Related]
3. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
[TBL] [Abstract][Full Text] [Related]
4. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
[TBL] [Abstract][Full Text] [Related]
5. [Adverse event after BCG vaccination in Poland in the years 1994-1997].
Szczuka I
Pneumonol Alergol Pol; 1999; 67(5-6):208-16. PubMed ID: 10570642
[TBL] [Abstract][Full Text] [Related]
6. Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren.
Dourado I; Rios MH; Pereira SM; Cunha SS; Ichihara MY; Goes JC; Rodrigues LC; Bierrenbach AL; Barreto ML
Int J Tuberc Lung Dis; 2003 Apr; 7(4):399-402. PubMed ID: 12729348
[TBL] [Abstract][Full Text] [Related]
7. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings.
Manissero D; Lopalco PL; Levy-Bruhl D; Ciofi Degli Atti ML; Giesecke J
Vaccine; 2008 Apr; 26(18):2253-9. PubMed ID: 18400344
[TBL] [Abstract][Full Text] [Related]
8. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine.
Hendry AJ; Dey A; Beard FH; Khandaker G; Hill R; Macartney KK
Commun Dis Intell Q Rep; 2016 Dec; 40(4):E470-E474. PubMed ID: 28043221
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
10. [Complications after BCG vaccination in the urban section of Lodź in the years 1994-5].
Pankowska A; Rozniecki J
Pneumonol Alergol Pol; 1997; 65(11-12):761-6. PubMed ID: 9760789
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
[TBL] [Abstract][Full Text] [Related]
12. [Modern microbiological methods in diagnosis of adverse reactions after BCG vaccination. Case reports].
Zwolska Z; Augustynowicz-Kopeć E; Zabost A; Ziółkowski J; Buchwald J; Płończak M; Walas W; Ziebiński M
Pneumonol Alergol Pol; 2004; 72(11-12):505-11. PubMed ID: 16329351
[TBL] [Abstract][Full Text] [Related]
13. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
14. [Adverse events following BCG vaccination].
Sagić L
Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
[TBL] [Abstract][Full Text] [Related]
15. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.
Al-Salem AH; Kothari MR; AlHani HM; Oquaish MM; Khogeer SS; Desouky MS
Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758
[TBL] [Abstract][Full Text] [Related]
16. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
Deeks SL; Clark M; Scheifele DW; Law BJ; Dawar M; Ahmadipour N; Walop W; Ellis CE; King A
Pediatr Infect Dis J; 2005 Jun; 24(6):538-41. PubMed ID: 15933565
[TBL] [Abstract][Full Text] [Related]
17. [HIV-infection, AIDS and BCG vaccination].
Toida I
Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
[TBL] [Abstract][Full Text] [Related]
18. Complications associated with the bacille Calmette-Guérin vaccination in Ireland.
Bolger T; O'Connell M; Menon A; Butler K
Arch Dis Child; 2006 Jul; 91(7):594-7. PubMed ID: 16547086
[TBL] [Abstract][Full Text] [Related]
19. [Results of the BCG vaccination in Hungary since 1929: evaluation of preventive and immunotherapeutic effectiveness].
Lugosi L
Orv Hetil; 1998 Jun; 139(26):1563-70. PubMed ID: 9676117
[TBL] [Abstract][Full Text] [Related]
20. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
